FRISSORA MARK P 4

4 · BIOADAPTIVES, INC. · Filed Jul 6, 2026

AI-generated summary of this filing

Updated Jul 6, 2026

BioAdapTives (BDPT) Director Mark Frissora Receives Award

What Happened

Mark P. Frissora, a director of BioAdapTives, acquired a derivative award on July 1, 2026 reported as 12,500 shares @ $0.00 (transaction coded as "Other acquisition or disposition (J)"). The filing indicates these are Series D Convertible Preferred Stock issued as board compensation under a February 3, 2025 board agreement. No cash was paid (reported value $0).
The Series D preferred converts into common stock at a ratio of 100 common shares per 1 preferred share, which implies the award represents 125 preferred shares (12,500 common-share equivalents).

Key Details

Transaction date: 2026-07-01; Filing date: 2026-07-06 (appears filed after the usual two-business-day Form 4 window).
Reported consideration: $0.00 (compensation award).
Shares owned after transaction: Not specified in the provided filing details.
Footnotes of note:
- F1: Award issued as compensation for board services pursuant to the Board of Directors Agreement (Feb 3, 2025).
- F2: Conversion ratio is 100 common shares per preferred share; conversion subject to a 4.9% beneficial ownership limitation; conversion not permitted until six months after issuance except upon liquidation; each preferred share carries 100 votes at stockholder meetings; conversion right does not expire.
Timeliness: Filing was submitted five days after the transaction date—later than the typical two-business-day Form 4 deadline.

Context

This was a compensation grant of convertible preferred stock (a derivative), not an open-market purchase or sale. Because conversion is restricted for six months and subject to a ownership cap, the award does not represent immediate common-stock buying power.
Compensation awards are common for board service and are informative about pay structure but do not necessarily signal the insider’s near-term view on the stock.

Form 4

Period: 2026-07-01

Director

Transactions

Other
Series D Convertible Preferred Stock
[F2][F1]
2026-07-01+12,500→ 88,771 total
From: 2027-01-01→ Common Stock (1,250,000 underlying)

Footnotes (2)

[F1]Represents shares of Series D Convertible Preferred Stock issued as compensation for board services pursuant to that certain Board of Directors Agreement, dated February 3, 2025, between the Issuer and the Reporting Person.
[F2]The Reporting Person's shares of Series D Convertible Preferred Stock, par value $0.0001 per share, are convertible into shares of common stock, par value $0.0001 per share, at a ratio of 100 shares of common stock for each share of Series D Convertible Preferred Stock, subject to a 4.9% beneficial ownership limitation. No shares of Series D Convertible Preferred Stock may be converted until six months after the date of issuance, except in the case of liquidation, whereupon the conversion will occur immediately. Each share of Series D Convertible Preferred Stock outstanding at the time of a meeting of stockholders or a solicitation of consent is entitled to 100 votes on matters of the Issuer, without regard to the beneficial ownership limitation. The right to convert does not expire.

Signature

/s/ Mark P. Frissora|2026-07-06

1 file